Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Vasopressin 1A receptor (V1aR), also known as AVPR1A, is a G protein-coupled receptor that binds arginine vasopressin. It is involved in vasoconstriction, social behavior modulation, and baroreflex regulation. It is highly expressed in the brain and peripherally in tissues like the liver, kidney, and blood vessels. Genetic variants are associated with differences in social communication traits and implicated in autism spectrum disorders and substance abuse vulnerability.
Activation leads primarily to rapid increases in cytosolic Ca²⁺ via Gq/11 signaling, activating phospholipase C pathway, leading to production of IP3 and DAG, mobilization of intracellular Ca²⁺, and activation of protein kinase C.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vasopressin 1A Receptor (V1a).